DIFFRACTION STUDIES OF BACTERIAL ENDOTOXINS

细菌内毒素的衍射研究

基本信息

  • 批准号:
    6120480
  • 负责人:
  • 金额:
    $ 0.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-09-15 至 1999-08-14
  • 项目状态:
    已结题

项目摘要

Delta endotoxins are the entomocidal agent produced by Bacillus thuringiensis ssp. Kurstaki. These toxins are produced as protoxins (135 kDa) by the bacteria during sporulation and recognized by their bipyrimidal crystalline form in the sporangium. When ingested by larval Lepidoptera the crystal dissolves and is proteolytically digested to the active toxin form (60-65 kDa). This activated toxin is capable of opening K+ channels in the epithelium of the insect midgut. Ion leakage ultimately results in the complete disruption of the midgut and death of the insect. More recently, a new active form of the toxin, CryIIIB2, has been determined (64 kDa). The bacterial endotoxin CryIIIB2 is a 652 residue protein which crystallizes in the orthorhombic space group C2221 with unit cell dimensions a = 122.44, b = 131.81, and c = 105.37& and contain one molecule in the asymmetric unit. Synchrontron radiation was used to collect 2.2& resolution data at the CHESS facility at Cornell University in December, 1997 by Vivian Cody and Nikolai Galitsky for the complex of EC11095 with D-galactosamine. Although these data were did not diffract uniformly to high resolution, Walt Pangborn was able to scale data with at least 50% completion for all shells to 2.2& resolution. The structure of the native CryIIIB2 was used as a search model for the rotation and translation function in the program XPLOR which revealed there was no significant change in the molecular orientation of the molecule compared to the room temperature model. The major consequence of low temperature data collection is the contraction of the unit cell along the a and b lattice directions. Interpretation of the difference electron density maps made from the 3.0& refinement model of the Arg-348 mutant of CryIIIB2 revealed a large density profile that clearly was not a cluster of solvent and that could be fit to the sugar. These data reveal that the galactosamine is positioned at the intersection of the three domains of CryIIIB2. Refinement of these data to 2.2& resolution suggest other potential sugar binding sites are possible.
三角洲内毒素是芽孢杆菌产生的杀虫剂

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vivian Cody其他文献

Vivian Cody的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vivian Cody', 18)}}的其他基金

STRUCTURAL STUDIES OF AIDS-RELATED ENZYMES AND OTHER PATHOGENIC TARGETS
艾滋病相关酶和其他致病靶标的结构研究
  • 批准号:
    8362410
  • 财政年份:
    2011
  • 资助金额:
    $ 0.02万
  • 项目类别:
PATHOGENIC PROTEIN INTERACTIONS
致病性蛋白质相互作用
  • 批准号:
    8363556
  • 财政年份:
    2011
  • 资助金额:
    $ 0.02万
  • 项目类别:
Structural Studies of AIDS-Responsive Drugs
艾滋病反应药物的结构研究
  • 批准号:
    8017787
  • 财政年份:
    2010
  • 资助金额:
    $ 0.02万
  • 项目类别:
Structural Studies of AIDS-Responsive Drugs
艾滋病反应药物的结构研究
  • 批准号:
    7888607
  • 财政年份:
    2009
  • 资助金额:
    $ 0.02万
  • 项目类别:
PROTEIN-PROTEIN INTERACTIONS OF DIHYDROFOLATE REDUCTASE
二氢叶酸还原酶的蛋白质-蛋白质相互作用
  • 批准号:
    6977201
  • 财政年份:
    2004
  • 资助金额:
    $ 0.02万
  • 项目类别:
DIFFRACTION OF BACTERIAL ENDOTOXINS: STRUCT BASED DRUG DESIGN, SCREEN PCP ENZYME
细菌内毒素的衍射:基于结构的药物设计,筛选 PCP 酶
  • 批准号:
    6667781
  • 财政年份:
    2002
  • 资助金额:
    $ 0.02万
  • 项目类别:
DIFFRACTION OF BACTERIAL ENDOTOXINS: STRUCT BASED DRUG DESIGN, SCREEN PCP ENZYME
细菌内毒素的衍射:基于结构的药物设计,筛选 PCP 酶
  • 批准号:
    6491104
  • 财政年份:
    2001
  • 资助金额:
    $ 0.02万
  • 项目类别:
DIFFRACTION OF BACTERIAL ENDOTOXINS: STRUCT BASED DRUG DESIGN, SCREEN PCP ENZYME
细菌内毒素的衍射:基于结构的药物设计,筛选 PCP 酶
  • 批准号:
    6339116
  • 财政年份:
    2000
  • 资助金额:
    $ 0.02万
  • 项目类别:
DIFFRACTION OF BACTERIAL ENDOTOXINS: STRUCT BASED DRUG DESIGN, SCREEN PCP ENZYME
细菌内毒素的衍射:基于结构的药物设计,筛选 PCP 酶
  • 批准号:
    6220476
  • 财政年份:
    1999
  • 资助金额:
    $ 0.02万
  • 项目类别:
DIFFRACTION STUDIES OF BACTERIAL ENDOTOXINS
细菌内毒素的衍射研究
  • 批准号:
    6281253
  • 财政年份:
    1998
  • 资助金额:
    $ 0.02万
  • 项目类别:

相似海外基金

Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
  • 批准号:
    10448926
  • 财政年份:
    2021
  • 资助金额:
    $ 0.02万
  • 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
  • 批准号:
    10491861
  • 财政年份:
    2021
  • 资助金额:
    $ 0.02万
  • 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
  • 批准号:
    10675535
  • 财政年份:
    2021
  • 资助金额:
    $ 0.02万
  • 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
  • 批准号:
    EP/S021868/1
  • 财政年份:
    2019
  • 资助金额:
    $ 0.02万
  • 项目类别:
    Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
  • 批准号:
    529840-2018
  • 财政年份:
    2018
  • 资助金额:
    $ 0.02万
  • 项目类别:
    Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
  • 批准号:
    1403724
  • 财政年份:
    2014
  • 资助金额:
    $ 0.02万
  • 项目类别:
    Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
  • 批准号:
    1403697
  • 财政年份:
    2014
  • 资助金额:
    $ 0.02万
  • 项目类别:
    Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
  • 批准号:
    131690
  • 财政年份:
    2014
  • 资助金额:
    $ 0.02万
  • 项目类别:
    Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
  • 批准号:
    131338
  • 财政年份:
    2013
  • 资助金额:
    $ 0.02万
  • 项目类别:
    Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
  • 批准号:
    429734-2011
  • 财政年份:
    2012
  • 资助金额:
    $ 0.02万
  • 项目类别:
    Experience Awards (previously Industrial Undergraduate Student Research Awards)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了